Amphastar Pharmaceuticals, Inc. Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31)
Amphastar Pharmaceuticals, Inc. (AMPH) reported Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) of -$54.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Equity
us-gaap:CumulativeEffectOnRetainedEarningsNetOfTax1 · last filed 2019-11-08
- Amphastar Pharmaceuticals, Inc. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2019-09-30 was $0.00.
- Amphastar Pharmaceuticals, Inc. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2019-06-30 was $0.00.
- Amphastar Pharmaceuticals, Inc. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2019-03-31 was -$54.00K, a 109.28% decline year-over-year.
- Amphastar Pharmaceuticals, Inc. cumulative effect on retained earnings, net of tax (deprecated 2020-01-31) for the quarter ending 2018-09-30 was $0.00.
| Period end | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 3 month | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 6 month | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) 9 month |
|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | -$54.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$54.00K 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | -$54.00K 10-Q · filed 2019-05-10 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $582.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $582.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $582.00K 10-Q · filed 2019-05-10 | |||
| 2018-01-01 | $582.00K 10-Q · filed 2018-08-09 | |||
| 2017-09-30 | $872.00K 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |